Filing Flows › Silence Therapeutics (SLN) › Q4 2025 › vs Q4 2024
Silence Therapeutics (SLN) Q4 2025 vs Q4 2024 (year over year)
Silence Therapeutics's revenue fell $25.3M (-100%) from $25.3M in Q4 2024 to $34K in Q4 2025.
Silence Therapeutics, Q4 2025: revenue $34K (-100% year over year), net loss $11.8M, operating cash flow −$17.3M. The chart draws each line against Q4 2024, the increases inside each band.
Every line
| Line | Q4 2025 | Q4 2024 | Change | % |
|---|---|---|---|---|
| Revenue | $34K | $25.3M | −$25.3M | -100% |
| Other income, net | $691K | $17.0M | −$16.3M | -96% |
| Net loss | $11.8M | −$12.3M | $24.1M | — |
| Costs & expenses | $12.5M | $42.3M | −$29.8M | -70% |
| Operating costs | $12.5M | $29.7M | −$17.2M | -58% |
| Cost of revenue | $12K | $2.0M | −$2.0M | -99% |
| Research & development | $8.7M | $22.1M | −$13.3M | -60% |
| General & admin | $3.7M | $5.5M | −$1.8M | -33% |
| Operating cash sources | $17.4M | $27.6M | −$10.2M | -37% |
| Depreciation | $77K | $76K | $1K | +1% |
| Cash used in operations | $17.3M | $27.5M | −$10.2M | -37% |
| Net loss absorbed | $11.8M | −$12.3M | $24.1M | — |
| Working capital & other | $5.6M | $43.8M | −$38.2M | -87% |
Questions
How much did Silence Therapeutics's revenue grow year over year in Q4 2025?
Silence Therapeutics's revenue fell $25.3M (-100%) from $25.3M in Q4 2024 to $34K in Q4 2025.